Mako Surgical (NSDQ:MAKO) shares are up nearly 16% so far this morning after the medical device company reported 2nd-quarter numbers that shattered expectations on Wall Street.
MassDevice Earnings Roundup
NuVasive swings to Q2 red as it reveals OIG probe
Sorin puts 2012 earthquake behind with 92% Q2 profit growth
Sorin Group (BIT:SRN) said it’s finally put the impact of a devastating earthquake behind it, reporting surging profit growth and a return to normal operations for the Italian plant hit by the temblor.
Greatbatch raises guidance on Q2 figures
Texas medical device maker Greatbatch (NYSE:GB) posted a profit in Q2 and nudged its 2013 per-share earnings guidance up for the 2nd time in 2 months. The device maker’s Q2’s sales eked out a 3% boost over last year’s figures and profits were up 10%, according to the financial release.
Haemonetics swings to Q1 red, lowers full-year guidance; Wall Street flees
Haemonetics Corp. (NYSE:HAE) took a Wall Street dip after posting a hard swing to the red and adjusted per-share earnings just shy of analysts’ expectations.
DJO Global posts modest revenue gains, widened losses
Medical device company DJO Global posted results for its publicly reported subsidiary DJO Finance, reported a 3% increase in revenues and a 3% widening of losses.
The San Diego, Calif. company reported losses of $20.8 million on sales of $294.7 million for the 3 months ended June 29, 2013. That compared with losses of $20.2 million on sales of $286 million during the same period in 2012.
Earnings boost, Wall Street dip for Stentys
Medical device maker Stentys SA (EPA:STNT) reported a big boost to its top line, but that didn’t win the company much love from Wall Street last week.
Vascular Solutions posts profits, boosts guidance estimates
Vascular Solutions‘ (NSDQ:VASC) Q2 earnings landed exactly within analyst expectations, ending the company’s long streak of beating the Street.
Despite driving profits up almost 20% and boosting guidance estimates to reflect healthy revenue, Wall Street responded by sending share prices down 0.7% by the end of the day.
Q2 profits surge for Edwards Lifesciences
Edwards Lifesciences (NYSE:EW) posted surging 2nd-quarter profits on modest sales growth, saying sales of its flagship Sapien heart valve reached $90 million for the quarter.
Invacare makes progress during ‘most challenging year’
NxStage Medical pares losses and boosts sales, but still takes a hit on Wall Street
NxStage Medical (NSDQ:NXTM) beat the Street’s earnings-per-share estimate by 1 penny and reported an 11% bump in sales, but it wasn’t enough to stop shares from sliding 4% this morning.